BRAF and melanoma: The obtained results showed that the LNPs that encapsulate the combinations of the two tumor suppressor miRNAs are highly efficient in inhibiting the proliferation and viability of melanoma cells, and potentiate the efficacy of drugs that inhibit BRAF and MEK.